Standout Papers

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial ... 2013 2026 2017 2021 482
  1. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (2013)
    Timothy M. Miller, Alan Pestronk et al. The Lancet Neurology

Citation Impact

1 by Nobel laureates 14 from Science/Nature 72 standout
Sub-graph 1 of 20

Citing Papers

Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Small and long non-coding RNAs: Past, present, and future
2024 Standout
1 intermediate paper

Works of William David being referenced

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
2013 Standout

Author Peers

Author Neurology Genetics Physiology Molecular Biology Last Decade Papers Cites
William David 494 358 89 426 17 939
Adrian Caplanusi 4 2 36 196 18 349
Ryan Randolph 1 3 41 10 240
Hesham Dahshan 1 39 17 363
Ana Teresa Fernandes 3 24 88 22 313
D. Crane 1 1 1 32 11 713

All Works

Loading papers...

Rankless by CCL
2026